Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

VTVT vTv Therapeutics Inc. Class A Common Stock
$35.25 16.01% +5.07
Notify me if price changes either direction
Interactive Brokers Logotype

Buy VTVT stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 138.4M
Enterprise value 294.7M
Trailing PE -10.968749523163
Forward PE -8.820281
PEG Ratio -0.48262497901916
Enterprise to EBITDA -9.897
Enterprise to revenue 17336.094
Price to book MRQ 6.1811786
Price to sales TTM 8140.1147

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 17000
EBITDA -29779000
Diluted EPS TTM -3.3
Total Cash (MRQ) 98.5M
Current ratio (MRQ) 9.786
Operating Cash Flow (TTM) -20829000

VTVT trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent VTVT News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.